Form 8.3 - [AbbVie Inc.]

Date : 01/17/2020 @ 2:38PM
Source : Dow Jones News
Stock : Allergan plc (AGN)
Quote : 190.67  1.15 (0.61%) @ 10:30PM
After Hours
Last Trade
Last $ 191.00 ▲ 0.33 (0.17%)

Form 8.3 - [AbbVie Inc.]

TIDM0QCV TIDM0Y7T 
 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               AbbVie Inc. 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.01 common stock 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                16(th) January 2020 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                69,033,038  4.66782% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  69,033,038  4.66782% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                               200                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                             9,756                    89.23 
--------------  -----------------------------  ----------------------- 
   Purchase                               371                    89.31 
--------------  -----------------------------  ----------------------- 
   Purchase                             5,500                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                               600                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                               100                    89.55 
--------------  -----------------------------  ----------------------- 
   Purchase                               200                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                                78                    89.44 
--------------  -----------------------------  ----------------------- 
   Purchase                            48,060                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                               232                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                               116                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                             9,380                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                            17,822                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                               206                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                               180                    89.26 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,535                    89.23 
--------------  -----------------------------  ----------------------- 
   Purchase                                40                    89.37 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,112                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                                 600                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                                 200                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                                 200                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                               2,600                    89.21 
--------------  -----------------------------  ----------------------- 
     Sale                               2,499                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                              22,250                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                              15,880                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                                 384                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                               8,616                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                               1,600                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                                 100                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                                 200                    89.24 
--------------  -----------------------------  ----------------------- 
     Sale                                 600                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                                 169                    89.26 
--------------  -----------------------------  ----------------------- 
     Sale                                 152                    89.26 
--------------  -----------------------------  ----------------------- 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                      NO 
-------------------------------------------------------  ------------------- 
Date of disclosure                                       17(th) January 2020 
-------------------------------------------------------  ------------------- 
Contact name                                                Lionel Colaco 
-------------------------------------------------------  ------------------- 
Telephone number                                                020 33956098 
-------------------------------------------------------  ------------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  ------------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  ------------------- 
 
 
 
 
 
 

(END) Dow Jones Newswires

January 17, 2020 09:23 ET (14:23 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Latest AGN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.